Accel Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-360
Closed -$86.9K 200
2023
Q1
$86.9K Sell
360
-9
-2% -$2.21K 0.04% 361
2022
Q4
$97K Hold
369
0.05% 243
2022
Q3
$86K Sell
369
-207
-36% -$50.2K 0.05% 268
2022
Q2
$143K Buy
576
+2
+0.3% +$490 0.08% 183
2022
Q1
$140K Buy
574
+2
+0.3% +$460 0.07% 205
2021
Q4
$129K Buy
572
+225
+65% +$47.5K 0.06% 225
2021
Q3
$74K Sell
347
-21
-6% -$4.83K 0.05% 266
2021
Q2
$90K Buy
368
+1
+0.3% +$246 0.06% 247
2021
Q1
$91K Sell
367
-21
-5% -$5.01K 0.07% 228
2020
Q4
$89K Buy
+388
New +$89.5K 0.08% 214

Other funds holding AMGN

Accel Wealth Management's AMGN Position: Q2 2023 in Review

Accel Wealth Management sold out of Amgen (AMGN) in Q2 2023, closing a stake of 360 shares — an estimated $86.9K sold.

Accel Wealth Management first reported a position in AMGN in Q4 2020 and held it in 10 quarters. The position peaked at $143K in Q2 2022. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Accel Wealth Management reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Accel Wealth Management sold 360 Amgen shares in Q2 2023, an estimated $86.9K.
  • Accel Wealth Management first reported a position in Amgen in Q4 2020 and held it in 10 quarters.
  • Accel Wealth Management's Amgen position peaked at $143K in Q2 2022.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.